Cargando…

Nanomedicine as a Promising Tool to Overcome Immune Escape in Breast Cancer

Breast cancer is the most common type of malignancy and leading cause of cancer death among women worldwide. Despite the current revolutionary advances in the field of cancer immunotherapy, clinical response in breast cancer is frequently below expectations, in part due to various mechanisms of canc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Navarro-Ocón, Alba, Blaya-Cánovas, Jose L., López-Tejada, Araceli, Blancas, Isabel, Sánchez-Martín, Rosario M., Garrido, María J., Griñán-Lisón, Carmen, Calahorra, Jesús, Cara, Francisca E., Ruiz-Cabello, Francisco, Marchal, Juan A., Aptsiauri, Natalia, Granados-Principal, Sergio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950730/ https://www.ncbi.nlm.nih.gov/pubmed/35335881 http://dx.doi.org/10.3390/pharmaceutics14030505

Ejemplares similares

TGFβ Governs the Pleiotropic Activity of NDRG1 in Triple-Negative Breast Cancer Progression
por: López-Tejada, Araceli, et al.
Publicado: (2023)

Antioxidants for the Treatment of Breast Cancer: Are We There Yet?
por: Griñan-Lison, Carmen, et al.
Publicado: (2021)

Drug Repurposing for Triple-Negative Breast Cancer
por: Ávalos-Moreno, Marta, et al.
Publicado: (2020)

The Escape of Cancer from T Cell-Mediated Immune Surveillance: HLA Class I Loss and Tumor Tissue Architecture
por: Garrido, Federico, et al.
Publicado: (2017)

Nanomedicines for Overcoming Cancer Drug Resistance
por: Hu, Tingting, et al.
Publicado: (2022)

Tumor Escape Phenotype in Bladder Cancer Is Associated with Loss of HLA Class I Expression, T-Cell Exclusion and Stromal Changes
por: Gil-Julio, Hernani, et al.
Publicado: (2021)

Roadmap and strategy for overcoming infusion reactions to nanomedicines
por: Szebeni, Janos, et al.
Publicado: (2018)

Harnessing nanomedicine to overcome the immunosuppressive tumor microenvironment
por: Sun, Bo, et al.
Publicado: (2020)

Cancer stem cell secretome in the tumor microenvironment: a key point for an effective personalized cancer treatment
por: López de Andrés, Julia, et al.
Publicado: (2020)

HLA class I loss and PD-L1 expression in lung cancer: impact on T-cell infiltration and immune escape
por: Perea, Francisco, et al.
Publicado: (2017)

CSC Radioresistance: A Therapeutic Challenge to Improve Radiotherapy Effectiveness in Cancer
por: Olivares-Urbano, María Auxiliadora, et al.
Publicado: (2020)

Stimuli-Responsive Nanomedicines for Overcoming Cancer Multidrug Resistance
por: Zhou, Lei, et al.
Publicado: (2018)

Overcoming Vascular Barriers to Improve the Theranostic Outcomes of Nanomedicines
por: Tang, Yufu, et al.
Publicado: (2022)

CAR-T Cells Hit the Tumor Microenvironment: Strategies to Overcome Tumor Escape
por: Rodriguez-Garcia, Alba, et al.
Publicado: (2020)

Late pulmonary metastases of renal cell carcinoma immediately after post-transplantation immunosuppressive treatment: a case report
por: Cozar, Jose Manuel, et al.
Publicado: (2008)

Enhancement of Tumor Cell Death by Combining gef Gene Mediated Therapy and New 1,4-Benzoxazepin-2,6-Dichloropurine Derivatives in Breast Cancer Cells
por: Ramírez, Alberto, et al.
Publicado: (2018)

NANOMEDICINE: will it offer possibilities to overcome multiple drug resistance in cancer?
por: Friberg, Sten, et al.
Publicado: (2016)

Editorial: Novel approaches aiming to overcome current nanomedicine limitations
por: Palomba, Roberto, et al.
Publicado: (2023)

Nanomedicine-based combination therapies for overcoming temozolomide resistance in glioblastomas
por: Wang, Chun, et al.
Publicado: (2023)

LdrB Toxin with In Vitro and In Vivo Antitumor Activity as a Potential Tool for Cancer Gene Therapy
por: Jiménez-Martínez, Yaiza, et al.
Publicado: (2019)

Recent Trends in Nanomedicine-Based Strategies to Overcome Multidrug Resistance in Tumors
por: Khan, Muhammad Muzamil, et al.
Publicado: (2022)

Therapeutic Strategies to Overcome Fibrotic Barriers to Nanomedicine in the Pancreatic Tumor Microenvironment
por: Tanaka, Hiroyoshi Y., et al.
Publicado: (2023)

Nanomedicine to Overcome Multidrug Resistance Mechanisms in Colon and Pancreatic Cancer: Recent Progress
por: Ortíz, Raúl, et al.
Publicado: (2021)

Nanomedicine in Pancreatic Cancer: Current Status and Future Opportunities for Overcoming Therapy Resistance
por: Greene, Michelle K., et al.
Publicado: (2021)

The potential role of nanomedicine in the treatment of breast cancer to overcome the obstacles of current therapies
por: Yang, Fan, et al.
Publicado: (2023)

Distinct mechanisms of loss of IFN-gamma mediated HLA class I inducibility in two melanoma cell lines
por: Rodríguez, Teresa, et al.
Publicado: (2007)

Validation of suitable normalizers for miR expression patterns analysis covering tumour heterogeneity
por: Morata-Tarifa, C., et al.
Publicado: (2017)

Towards Curative Cancer Immunotherapy: Overcoming Posttherapy Tumor Escape
por: Zhou, Gang, et al.
Publicado: (2012)

Small molecule immunomodulation: the tumor microenvironment and overcoming immune escape
por: Osipov, Arsen, et al.
Publicado: (2019)

Copy Neutral LOH Affecting the Entire Chromosome 6 Is a Frequent Mechanism of HLA Class I Alterations in Cancer
por: Garrido, Maria Antonia, et al.
Publicado: (2021)

Nanomedicine: Application Areas and Development Prospects
por: Boulaiz, Houria, et al.
Publicado: (2011)

Overcoming viral escape with vaccines that generate and display antigen diversity in vivo
por: García-Quintanilla, Albert
Publicado: (2007)

Exosome: A New Player in Translational Nanomedicine
por: Aheget, Houssam, et al.
Publicado: (2020)

Low adherent cancer cell subpopulations are enriched in tumorigenic and metastatic epithelial-to-mesenchymal transition-induced cancer stem-like cells
por: Morata-Tarifa, Cynthia, et al.
Publicado: (2016)

Deciphering the Mechanism of Action Involved in Enhanced Suicide Gene Colon Cancer Cell Killer Effect Mediated by Gef and Apoptin
por: Cáceres, Blanca, et al.
Publicado: (2019)

Pancreatic (pro)enzymes treatment suppresses BXPC-3 pancreatic Cancer Stem Cell subpopulation and impairs tumour engrafting
por: Hernández-Camarero, Pablo, et al.
Publicado: (2019)

Unraveling the Potential of miRNAs from CSCs as an Emerging Clinical Tool for Breast Cancer Diagnosis and Prognosis
por: Nogueras Pérez, Raquel, et al.
Publicado: (2023)

Dual Targeting of Cancer Cells with DARPin-Based Toxins for Overcoming Tumor Escape
por: Shramova, Elena, et al.
Publicado: (2020)

Caffeine and Chlorogenic Acid Combination Attenuate Early-Stage Chemically Induced Colon Carcinogenesis in Mice: Involvement of oncomiR miR-21a-5p
por: Bartolomeu, Ariane Rocha, et al.
Publicado: (2022)

Nanomedicine
por: Howard, Kenneth A, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7sii5dbmfm0ph30gmd9j4fq8oj